Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
20,250,000
-
Total 13F shares
-
2,080,875
-
Share change
-
+1,994,190
-
Total reported value
-
$13,711,600
-
Put/Call ratio
-
3.4%
-
Price per share
-
$6.59
-
Number of holders
-
23
-
Value change
-
+$13,093,583
-
Number of buys
-
22
-
Number of sells
-
1
Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) as of Q4 2021
As of 31 Dec 2021,
enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,080,875 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, ACT CAPITAL MANAGEMENT, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., TWO SIGMA ADVISERS, LP, GEODE CAPITAL MANAGEMENT, LLC, Velan Capital Investment Management LP, TWO SIGMA INVESTMENTS, LP, MORGAN STANLEY, and Kepos Capital LP.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.